CervoMed Announces Data From Its Phase 2a Clinical Study Of Nonfluent Variant Primary Progressive Aphasia Shows Reduction In Mean Plasma Levels Of Neurofilament Light Chain

Benzinga

2026.10.12 11:36 (GMT+0)

Открыть на Benzinga